AL
BIO icon

Arnhold LLC’s Bio-Rad Laboratories Class A BIO Stock Holding History

Arnhold LLC’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.3M Buy
55,568
+12,666
+30% +$3.59M 1.14% 32
2026
Q1 		$12M Buy
42,902
+8,118
+23% +$2.34M 0.88% 35
2025
Q4 		$10.5M Hold
34,784
– – 0.8% 38
2025
Q3 		$9.75M Hold
34,784
– – 0.82% 35
2025
Q2 		$8.39M Buy
+34,784
New +$8.22M 0.77% 35

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Arnhold LLC's BIO Position: Q2 2026 in Review

Arnhold LLC increased its Bio-Rad Laboratories Class A (BIO) stake by 30% in Q2 2026, buying an estimated $3.59M and bringing the position to 55,568 shares worth $16.3M. The position accounts for 1.14% of the portfolio, ranked #32.

Arnhold LLC first reported a position in BIO in Q2 2025 and has held it in 5 quarters since. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Arnhold LLC held 55,568 shares of Bio-Rad Laboratories Class A worth $16.3M as of Q2 2026.
  • Arnhold LLC bought 12,666 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $3.59M.
  • Bio-Rad Laboratories Class A made up 1.14% of Arnhold LLC's portfolio in Q2 2026, its #32 holding.
  • Arnhold LLC first reported a position in Bio-Rad Laboratories Class A in Q2 2025 and has held it in 5 quarters since.
  • 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Arnhold LLC's 13F filing for Q2 2026, filed 27 Jul 2026.